Predict your next investment

Venture Capital
5amventures.com

See what CB Insights has to offer

Investments

215

Portfolio Exits

47

Funds

9

Partners & Customers

1

Service Providers

1

About 5AM Ventures

5AM Ventures is a seed and early-stage venture capital firm focused on building life science companies. 5AM Ventures was founded in 2002 and is based in San Francisco, California.

5AM Ventures Headquarter Location

501 Second Street Suite 350

San Francisco, California, 94107,

United States

415-993-8570

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest 5AM Ventures News

Magnetic Insight Raises $17M in Series B Funding

Jun 23, 2022

Magnetic Insight , an Alameda, Calif.-based imaging diagnostics company, raised $17m in Series B funding. The round was led by Celesta Capital, with participation from Alumni Ventures Group, Gaingels, and others, along with existing investors 5AM Ventures and Sand Hill Angels. The company intends to use the funds for the continued growth and expansion of its innovative Magnetic Particle Imaging (MPI) technology into clinical applications. Magnetic Insight’s goal is to offer clinicians a method to directly monitor cell therapy, enabling better and earlier clinical decisions, and optimal clinical outcomes. Their initial clinical application will focus on using MPI technology to monitor cell therapy (e.g., CAR-T, NK) in cancer patients. Cell therapy has fundamentally changed the cancer treatment landscape, showing impressive results in blood cancers such as leukemia and lymphoma. Unfortunately, the solid tumor landscape has proven more challenging due to an immunosuppressive tumor microenvironment that frequently excludes or inhibits cell therapy. Currently, there is no direct imaging method to monitor cell therapy localization in solid tumors to predict and monitor treatment responses. “Bringing MPI to the clinic is where we will get to see this phenomenal technology flourish and directly impact patient outcomes,” said  Led by Patrick Goodwill, CEO, CTO, and Co-founder, and Steven Conolly, PhD, Co-founder of Magnetic Insight, the Cook Professor of Bioengineering, and a Professor of Electrical Engineering & Computer Sciences at UC Berkeley, Magnetic Insight has advanced magnetic particle imaging (MPI), a new diagnostic and monitoring technology platform that allows clinicians to directly monitor a cancer patient’s cell therapy location, migration, persistence, and quantity to inform clinical decision making. By directly imaging cell therapy in each patient, MPI captures cellular-level information unavailable from conventional imaging modalities, including CT, MRI, or nuclear medicine. Having started in the preclinical space by selling small animal products to leading universities worldwide, the company is now scaling up MPI technology for clinical use. The suite includes the Momentum CT MPI imager, VivoTrax and VivoTrax+ reagents, Relax MPI relaxometry software, and MagImage imaging analysis software. Multiple academic medical centers are utilizing Magnetic Insight products including Stanford Medicine, Michigan State University, University of Florida, Robarts Research Institute, Wenzhou Medical University, Karolinska Institute, University of New South Wales, Johns Hopkins University, and others. FinSMEs

5AM Ventures Investments

215 Investments

5AM Ventures has made 215 investments. Their latest investment was in Magnetic Insight as part of their Series B on June 6, 2022.

CBI Logo

5AM Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/23/2022

Series B

Magnetic Insight

$17M

No

3

4/29/2022

Series C

Portal Instruments

$7M

No

1

4/21/2022

Series A

Dianthus Therapeutics

$100M

Yes

2

2/11/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

11/10/2021

Series D

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/23/2022

4/29/2022

4/21/2022

2/11/2022

11/10/2021

Round

Series B

Series C

Series A

Series B

Series D

Company

Magnetic Insight

Portal Instruments

Dianthus Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$17M

$7M

$100M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

1

2

10

10

5AM Ventures Portfolio Exits

47 Portfolio Exits

5AM Ventures has 47 portfolio exits. Their latest portfolio exit was CinCor Pharma on January 07, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/7/2022

IPO

4

12/6/2021

Reverse Merger

$99M

8

10/29/2021

IPO

$99M

7

8/5/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

7/29/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/7/2022

12/6/2021

10/29/2021

8/5/2021

7/29/2021

Exit

IPO

Reverse Merger

IPO

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

4

8

7

10

10

5AM Ventures Acquisitions

1 Acquisition

5AM Ventures acquired 1 company. Their latest acquisition was Borean Pharma on January 15, 2008.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/15/2008

Series B

$99M

$18.46M

Asset Sale

1

Date

1/15/2008

Investment Stage

Series B

Companies

Valuation

$99M

Total Funding

$18.46M

Note

Asset Sale

Sources

1

5AM Ventures Fund History

9 Fund Histories

5AM Ventures has 9 funds, including 5AM Ventures VII.

Closing Date

Fund

Fund Type

Status

Amount

Sources

4/4/2022

5AM Ventures VII

$450M

1

4/4/2022

5AM Opportunities II

$99M

10

2/13/2019

5AM Opportunities I

Subscribe to see more

Subscribe to see more

$99M

10

2/13/2019

5AM Ventures VI

Subscribe to see more

Subscribe to see more

$99M

10

5/27/2016

5AM Ventures V

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

4/4/2022

4/4/2022

2/13/2019

2/13/2019

5/27/2016

Fund

5AM Ventures VII

5AM Opportunities II

5AM Opportunities I

5AM Ventures VI

5AM Ventures V

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$450M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

5AM Ventures Partners & Customers

1 Partners and customers

5AM Ventures has 1 strategic partners and customers. 5AM Ventures recently partnered with Scientist.com on June 6, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

6/2/2019

Partner

United States

Scientist.com Partners With 5AM Ventures to Create an R&D Marketplace for Biotech Startups

SAN DIEGO -- -- Scientist.com , the world 's largest marketplace for outsourced R&D services , today announced a partnership with 5AM Ventures , a leading venture capital firm focused on building next-generation life science companies .

1

Date

6/2/2019

Type

Partner

Business Partner

Country

United States

News Snippet

Scientist.com Partners With 5AM Ventures to Create an R&D Marketplace for Biotech Startups

SAN DIEGO -- -- Scientist.com , the world 's largest marketplace for outsourced R&D services , today announced a partnership with 5AM Ventures , a leading venture capital firm focused on building next-generation life science companies .

Sources

1

5AM Ventures Service Providers

1 Service Provider

5AM Ventures has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

5AM Ventures Team

15 Team Members

5AM Ventures has 15 team members, including current Founder, Managing Partner, Andrew J. Schwab.

Name

Work History

Title

Status

John D. Diekman

Founder

Current

Andrew J. Schwab

Bay City Capital

Founder, Managing Partner

Current

Jeremy P. Springhorn

Chief Executive Officer

Current

Stephen Bonelli

Chief Financial Officer

Current

Rebecca Lucia

Chief Financial Officer

Current

Name

John D. Diekman

Andrew J. Schwab

Jeremy P. Springhorn

Stephen Bonelli

Rebecca Lucia

Work History

Bay City Capital

Title

Founder

Founder, Managing Partner

Chief Executive Officer

Chief Financial Officer

Chief Financial Officer

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.